Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications.
about
SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGYResistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible IsolatesMultilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system.The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.Transcription factor ADS-4 regulates adaptive responses and resistance to antifungal azole stressCell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the HostTotal Protein Profile and Drug Resistance in Candida albicans Isolated from Clinical Samples.Antiproliferation of Berberine in Combination with Fluconazole from the Perspectives of Reactive Oxygen Species, Ergosterol and Drug Efflux in a Fluconazole-Resistant Candida tropicalis Isolate.Current status of antifungal resistance and its impact on clinical practice.Acquired multi-azole resistance in Candida tropicalis during persistent urinary tract infection in a dog.Drug resistance mechanisms and their regulation in non-albicans Candida species.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida speciesCandida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae.Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system.An Update on Candida tropicalis Based on Basic and Clinical ApproachesDrug resistance and treatment failure in leishmaniasis: A 21st century challenge.Candida glabrata Biofilms: How Far Have We Come?MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.Widespread amphotericin B-resistant strains of in Hamilton, Canada
P2860
Q26783197-C86E6271-71F0-4B72-89B1-55D7F67D54F4Q28833536-471EF13B-9E26-4E7E-A331-55D17136CE67Q33622915-910092EB-55B5-4898-8F13-BDA8AA26D001Q33680814-2219508F-4963-4F4D-AE85-260BEBE83FF7Q34596780-D0A86FE0-9F7C-4A79-8644-CB08122B6E32Q35960980-6B2DE2A1-74EE-44C8-BE50-799B0D49A28FQ36729978-661B1F8E-2689-43AA-A21B-13A725DDF546Q37120840-51EA4CC5-F398-4D11-BBC9-7100C7CA2E59Q37279005-B4915CB4-BD70-4DFE-B65A-B005B5DD30FEQ38205859-922A8074-3841-47F8-B44D-A2A5E8D0EA6DQ38563343-C6215746-539E-4B22-B1D9-F8ABE6E40811Q38708362-C849E661-A7D3-4E73-9764-65CF64BA11ABQ38711698-C95273E8-D0B6-4F1E-A248-1486B3D2A53AQ39338332-5AF338AC-77F2-4C72-A764-9ED92B2473DAQ39388869-36A20EB7-D2AC-426B-996B-41E8C4DF5BE6Q40640348-8D8A6A3A-396A-4B54-8BA7-68CB63ED011EQ41633108-49C1A6A2-EBAA-4B26-AB83-C6A4AB033832Q42682766-C64B2673-0CB0-47A4-BB28-6495E0C889D7Q46380663-CCB378FF-74A8-4BE2-80A1-3308A77A62DCQ48163274-93E60D80-A566-4A3E-B66B-57596DCB59B0Q52598225-5D85E93E-CD48-45ED-B697-121385EC42BAQ53622505-9A642AAA-37F6-4BB7-B7AA-FDC6D017E3CCQ57071871-715AD47F-D866-45DA-99C9-15E861F5F681
P2860
Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Candida tropicalis antifungal ...... target (Erg11p) modifications.
@en
Candida tropicalis antifungal cross-resistance is related to different azole target
@nl
type
label
Candida tropicalis antifungal ...... target (Erg11p) modifications.
@en
Candida tropicalis antifungal cross-resistance is related to different azole target
@nl
prefLabel
Candida tropicalis antifungal ...... target (Erg11p) modifications.
@en
Candida tropicalis antifungal cross-resistance is related to different azole target
@nl
P2093
P2860
P50
P356
P1476
Candida tropicalis antifungal ...... target (Erg11p) modifications
@en
P2093
A C Mesa-Arango
A Forastiero
A Gomez-Lopez
L Alcazar-Fuoli
L Bernal-Martinez
P2860
P304
P356
10.1128/AAC.00477-13
P407
P577
2013-07-22T00:00:00Z